Related references
Note: Only part of the references are listed.Phylogeography and transmission of Mycobacterium tuberculosis spanning prisons and surrounding communities in Paraguay
Gladys Estigarribia Sanabria et al.
NATURE COMMUNICATIONS (2023)
Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis
Michael B. Hall et al.
LANCET MICROBE (2023)
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Jose Dominguez et al.
LANCET INFECTIOUS DISEASES (2023)
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan
Yu-Xin Xiao et al.
Scientific Reports (2023)
Transporter Associated with Antigen Processing 1 Gene Polymorphisms Increase the Susceptibility to Tuberculosis
Tianchang Lu et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2023)
New insights on tuberculosis transmission dynamics and drug susceptibility profiles among the prison population in Southern Brazil based on whole-genome sequencing
Livia Maria Pala Anselmo et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2023)
Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy
Hung-Ling Huang et al.
CLINICAL INFECTIOUS DISEASES (2022)
Time for Isoniazid Pharmacogenomic-Guided Therapy of Tuberculosis Based on NAT2 Acetylation Profiles in India
Nikhat Khan et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2022)
Nanopore Sequencing for Mycobacterium tuberculosis: a Critical Review of the Literature, New Developments, and Future Opportunities
Anzaan Dippenaar et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2022)
NAT2 polymorphism and clinical factors that increased antituberculosis drug-induced hepatotoxicity
Nur Farhana Mohamed Noor et al.
PHARMACOGENOMICS (2022)
Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study
Luis C. Berrocal-Almanza et al.
LANCET PUBLIC HEALTH (2022)
The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study
Henan Xin et al.
MICROBIOLOGY SPECTRUM (2022)
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
Timothy M. Walker et al.
LANCET MICROBE (2022)
AI-Assisted Tuberculosis Detection and Classification from Chest X-Rays Using a Deep Learning Normalization-Free Network Model
Vasundhara Acharya et al.
COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2022)
Multidrug-resistant tuberculosis in Finland: treatment outcome and the role of whole-genome sequencing
Virve Korhonen et al.
ERJ OPEN RESEARCH (2022)
Whole genome sequencing for tuberculosis in Victoria, Australia: A genomic implementation study from 2017 to 2020
Katie Dale et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)
Portable digital X-ray for TB pre-diagnosis screening in rural communities in Nigeria
B. Odume et al.
PUBLIC HEALTH ACTION (2022)
Making cough count in tuberculosis care
Alexandra J. Zimmer et al.
COMMUNICATIONS MEDICINE (2022)
Alert sign and symptoms for the early diagnosis of pulmonary tuberculosis: analysis of patients followed by a tertiary pediatric hospital
Elisa Farina et al.
ITALIAN JOURNAL OF PEDIATRICS (2022)
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB
Silke Feuerriegel et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
CYP2C8 and CYP2E1 genetic variants increase risk of tuberculosis in northwest Chinese Han population
Shishi Xing et al.
INFECTION GENETICS AND EVOLUTION (2021)
Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing
Alice Kizny Gordon et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Automatic cough classification for tuberculosis screening in a real-world environment
Madhurananda Pahar et al.
PHYSIOLOGICAL MEASUREMENT (2021)
Identifying Drug-Resistant Tuberculosis in Chest Radiographs: Evaluation of CNN Architectures and Training Strategies
Manohar Karki et al.
2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC) (2021)
Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis
M. Keikha et al.
NEW MICROBES AND NEW INFECTIONS (2021)
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
Leonardo Martinez et al.
LANCET (2020)
Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples
Andrea M. Cabibbe et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV
Pranav Rajpurkar et al.
NPJ DIGITAL MEDICINE (2020)
Tuberculin skin test - Outdated or still useful for Latent TB infection screening?
Gina Gualano et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury A prospective study
Mengyuan Lyu et al.
MEDICINE (2019)
Transmission dynamics study of tuberculosis isolates with whole genome sequencing in southern Sweden
Nader Alaridah et al.
SCIENTIFIC REPORTS (2019)
Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G > A Polymorphism in Adults with Pulmonary Tuberculosis
Marc Weiner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings?
Brian Wahl et al.
BMJ GLOBAL HEALTH (2018)
Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis
Albert Dompreh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis
Derek J. Sloan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Association of the miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms with susceptibility to pulmonary tuberculosis in the Chinese Uygur, Kazak and Southern Han populations
Xing Zhang et al.
BMC INFECTIOUS DISEASES (2015)
Use of chest radiography in the 22 highest tuberculosis burden countries
Tripti Pande et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Risk factors associated with adverse reactions to antituberculosis drugs
Laise Soares Oliveira Resende et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2015)
PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data
Silke Feuerriegel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes
Andreas Steiner et al.
BMC GENOMICS (2014)
Differential findings regarding molecular epidemiology of tuberculosis between two consecutive periods in the context of steady increase of immigration
J. Inigo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
NAT2 sequence polymorphisms and acetylation profiles in Indians
Naazneen Khan et al.
PHARMACOGENOMICS (2013)
Interleukin-6: a potent biomarker of mycobacterial infection
Prati Pal Singh et al.
SPRINGERPLUS (2013)
Innate Immune Gene Polymorphisms in Tuberculosis
Abul K. Azad et al.
INFECTION AND IMMUNITY (2012)
NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption
Sang-Heon Kim et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Tuberculosis chemotherapy in the 21st century: Back to the basics
Jyotsna M. Joshi
LUNG INDIA (2011)
Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
Marc Weiner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients
Katsumi Fukino et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2008)
Aminoglycoside-induced ototoxicity
Erol Selimoglu
CURRENT PHARMACEUTICAL DESIGN (2007)
Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
M Kinzig-Schippers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)